Breathe Well Live Well
NutraIngredients.com |
Dietary fibres may protect against asthma: Mouse data
NutraIngredients.com A lack of fermentable fibres in people's diet may pave the way for allergic inflammatory reactions such as asthma – and increasing intake of these fibres could help battle asthma, according to new research. |
View full post on asthma – Google News
|
CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data …
PR Newswire (press release) AUSTIN, Texas, Sept. 18, 2013 /PRNewswire/ — The Clinical Data Interchange Standards Consortium (CDISC) and TransCelerate BioPharma Inc. ("TransCelerate"), are pleased to announce that version 1.0 of the Asthma Therapeutic Area (TA) Data Standard … |
View full post on asthma – Google News
|
Vermont publishes asthma data and state plan on World Asthma Day – VTDigger
vtdigger.org BURLINGTON – Vermont, a rural state known for its open spaces, clean air and relative absence of industrialization, has one of the highest rates of asthma in the nation. One in 10 Vermont children and approximately 11 percent of adults had asthma in 2010. |
View full post on asthma – Google News
|
Boehringer Ingelheim presents positive efficacy data for tiotropium in asthma …
The Pharma Letter German family-owned drug major Boehringer Ingelheim presented a new subset of data from the Phase III UniTinA-asthma program relating to its already-marketed drug Spiriva (tiotropium) at the 2013 American Academy of Allergy, Asthma & Immunology … Boehringer Ingelheim drug shows benefits in new asthma trial |
View full post on asthma – Google News
|
New data from Boehringer Ingelheim's tiotropium Respimat Phase III UniTinA …
News-Medical.net These were the main findings from a new subset of data from the Phase III UniTinA-asthma® programme presented for the first time today at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San Antonio, Texas. Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic … |
View full post on asthma – Google News
|
Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic …
PR Newswire (press release) SAN ANTONIO, Feb. 23, 2013 /PRNewswire/ — Boehringer Ingelheim presented today a new subset of data from the Phase III UniTinA-asthma™ program at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San … |
View full post on asthma – Google News
|
Data Center: Childhood asthma hospitalization rate by ZIP code
San Jose Mercury News Data Center: Childhood asthma hospitalization rate by ZIP code. Daniel J. Willis and Katy Murphy Bay Area News Groupcontracostatimes.com. Posted: 02/09/2013 03:45:02 PM PST. February 9, 2013 11:45 PM GMTUpdated: 02/09/2013 03:45:27 PM PST … |
View full post on asthma – Google News
 Government Technology |
Big Data Takes on Chronic Disease
Government Technology A chronic disease that follows sufferers throughout their lives, asthma brings respiratory symptoms like shortness of breath, coughing, wheezing and chest tightness, which can limit daily activities, and therefore quality of life. Most symptoms can be … |
View full post on asthma – Google News
|
New data from Boehringer Ingelheim and Pfizer's tiotropium clinical studies on …
News-Medical.net New data to be presented at the Annual Congress of the European Respiratory Society (ERS 2012), in Vienna, Austria, will shed light on the current and potential future role of tiotropium, the first once-daily long-acting inhaled anticholinergic for … BOEHRINGER INGELHEIM GMBH : Key results from new tiotropium studies in … |
View full post on asthma – Google News
|
Positive Data on MediciNova's MN-221 – Analyst Blog
NASDAQ MediciNova is developing MN-221, a highly selective beta(2)-adrenergic receptor agonist, for the treatment of acute exacerbations of asthma and COPD. In 2004, MediciNova licensed exclusive rights to MN-221 from Kissei Pharmaceutical Co., Ltd. in all … Drug trial signals hope for asthma sufferers MediciNova Announces Positive Preliminary Results From a Multi-Day, Repeat … Illinois Investor Commits to Buy MediciNova Stock |
View full post on asthma – Google News